PT Kalbe Farma Tbk.

General ticker "PTKFF" information:

  • Sector: Health Care
  • Industry: Drug Manufacturers - General
  • Capitalization: $3.5B (TTM average)

PT Kalbe Farma Tbk. does not follow the US Stock Market performance with the rate: -20.8%.

Estimated limits based on current volatility of 2.9%: low 0.06$, high 0.06$

Factors to consider:

  • Company pays dividends (annually): last record date 2025-06-05, amount 0.00$ (Y0.00%)

Similar symbols

Short-term PTKFF quotes

Long-term PTKFF plot

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue IDR30,449,134.08MM IDR32,627,776.11MM IDR35,324,544.00MM
Operating Expenses IDR26,818,297.56MM IDR28,560,329.75MM IDR30,779,527.00MM
Operating Income IDR3,630,836.52MM IDR4,067,446.35MM IDR4,545,017.00MM
Non-Operating Income IDR-24,599.31MM IDR151,427.92MM IDR233,458.00MM
Interest Expense IDR95,103.84MM IDR56,320.23MM IDR35,247.00MM
R&D Expense IDR329,621.04MM IDR471,599.96MM IDR499,711.00MM
Income(Loss) IDR3,606,237.20MM IDR4,218,874.27MM IDR4,778,475.00MM
Taxes IDR827,832.38MM IDR972,304.52MM IDR1,034,100.00MM
Profit(Loss)* IDR2,766,748.04MM IDR3,240,636.63MM IDR3,664,998.00MM
Stockholders Equity IDR21,418,856.50MM IDR22,788,879.43MM IDR23,312,457.00MM
Inventory IDR6,791,979.79MM IDR6,501,631.20MM IDR6,985,130.00MM
Assets IDR27,057,568.18MM IDR29,429,727.90MM IDR30,699,348.00MM
Operating Cash Flow IDR2,907,475.17MM IDR4,785,179.04MM IDR3,270,655.00MM
Capital expenditure IDR1,178,972.22MM IDR1,250,335.29MM IDR809,872.00MM
Investing Cash Flow IDR-1,140,786.69MM IDR-1,247,287.97MM IDR-799,892.00MM
Financing Cash Flow IDR-2,443,986.34MM IDR-2,091,905.54MM IDR-2,869,280.00MM
Earnings Per Share** IDR59.81 IDR70.22 IDR80.51

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.